Hinoin Pharmaceutical and Chemical Product Plant

Chinoin is a historic Hungarian pharmaceutical company that currently operates as a strategic subsidiary of the global healthcare leader Sanofi. Established in 1910, it has grown into one of the largest pharmaceutical manufacturers in Central and Eastern Europe, specializing in the production of active pharmaceutical ingredients (APIs) and finished medicinal products. The company is well-known for developing legacy products such as the antispasmodic No-Spa (drotaverine) and the cough suppressant Libexin. Today, Chinoin's facilities in Budapest, Veresegyház, and Miskolc serve as critical nodes in Sanofi's global manufacturing and distribution network. Its operations encompass chemical synthesis, large-scale pharmaceutical production, and regional distribution across multiple therapeutic areas including cardiovascular health and diabetes.